FY2025 · ended May 31, 2025 · Revenue $303,022, +21.8% YoY · Filed Sep 22, 2025
Cannabis Bioscience International Holdings, Inc. (CBIH) files with the SEC under industry code 8731, Services-Commercial Physical & Biological Research. In fiscal 2025, which ended May 31, 2025, it reported revenue of $303,022 and a net loss of $548,820. As of Feb 28, 2026 it held $90 in cash and investments and $290,865 in total debt.
Revenue (TTM)
$123,627
-64.1% vs year-ago TTM
Net income (TTM)
$-515,290
-8.9% vs year-ago TTM
Operating cash flow (TTM)
$-268,114
+25.5% vs year-ago TTM
Free cash flow
—
EPS (TTM)
$-0.00
+0.5% vs year-ago TTM
Dividend per share
None
Shares outstanding
11.63B
+11.5% vs prior year
Net cash
$-290,775
as of Feb 28, 2026
Operating margin
-322.6%
FY 2026
Company profile
- Industry
- Services-Commercial Physical & Biological Research (SIC 8731)
- Listed as
- CBIH (OTC)
- Fiscal year ends
- May 31
- Incorporated in
- CO
- Headquarters
- Yantis, TX
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1411057
- Former names
- CHINA INFRASTRUCTURE CONSTRUCTION Corp (until Aug 24, 2022); FIDELITY AVIATION CORP (until Sep 15, 2009)
Other Services-Commercial Physical & Biological Research companies
- Iqvia Holdings Inc. IQV
- Incyte Corp INCY
- Medpace Holdings, Inc. MEDP
- Charles River Laboratories International, Inc. CRL
- Icon PLC ICLR
- Absci Corp ABSI
- OmniAb, Inc. OABI
- NRC Health NRC
All 17 Services-Commercial Physical & Biological Research companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 May 31, 2025 |
FY 2024 May 31, 2024 |
|---|---|---|
| Revenue | $303,022 | $248,841 |
| Operating income | -$421,365 | -$486,140 |
| Net income | -$548,820 | -$651,345 |
| Diluted EPS | -$0.00 | -$0.00 |
| Operating cash flow | -$329,627 | -$479,382 |
| Total assets | $31,880 | $57,162 |
| Total liabilities | $1.2M | $1.1M |
| Stockholders' equity | -$1.2M | -$1.1M |
| Cash and investments | $12,952 | $755 |
| Total debt | $291,093 | $283,288 |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Apr 16, 2026 | Feb 28, 2026 |
| 10-Q | Quarterly report | Feb 19, 2026 | Nov 30, 2025 |
| 10-Q | Quarterly report | Oct 22, 2025 | Aug 31, 2025 |
| 10-K | Annual report | Sep 22, 2025 | May 31, 2025 |
| 10-Q/A | Amended quarterly report | May 9, 2025 | Feb 28, 2025 |
| 10-Q | Quarterly report | Apr 22, 2025 | Feb 28, 2025 |
All 143 Cannabis Bioscience International Holdings, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.